Medications for Inflammatory Breast Carcinoma

2 results
  • perjeta - pertuzumab injection, solution, concentrate

    (Pertuzumab)
    Genentech, Inc.
    Perjeta is used with trastuzumab and chemotherapy to treat HER2-positive breast cancer in adults. Indicated for metastatic breast cancer without prior anti-HER2 therapy, neoadjuvant treatment of locally advanced or early-stage breast cancer, and adjuvant treatment of early breast cancer at high risk of recurrence.
  • phesgo - pertuzumab, trastuzumab, and hyaluronidase - zzxf injection, solution

    (Pertuzumab, Trastuzumab, And Hyaluronidase-Zzxf)
    Genentech, Inc.
    Phesgo (pertuzumab, trastuzumab, hyaluronidase) treats HER2-positive breast cancer in adults: neoadjuvant and adjuvant treatment with chemotherapy for early-stage breast cancer, and with docetaxel for metastatic breast cancer in patients who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.